Related Experiment Videos
Assessment of relative brain iron concentrations using T2-weighted and T2*-weighted MRI at 3 Tesla
R J Ordidge1, J M Gorell, J C Deniau
1Department of Neurology, Henry Ford Hospital & Health Sciences Center, Detroit, Michigan.
Abstract:
In this paper a new method is presented for the relative assessment of brain iron concentrations based on the evaluation of T2 and T2*-weighted images. A multiecho sequence is employed for rapid measurement of T2 and T2*, enabling calculation of the line broadening effect (T2'). Several groups have failed to show a correlation between T2 and brain iron content. However, quantification of T2', and the associated relaxation rate R2', may provide a more specific relative measure of brain iron concentration. This may find application in the study of brain diseases, which cause associated changes in brain iron levels. A new method of field inhomogeneity correction is presented that allows the separation of global and local field inhomogeneities, leading to more accurate T2* measurements and hence, T2' values. The combination of T2*, and T2-weighted MRI methods enables the differentiation of Parkinson's disease patients from normal age-matched controls based on differences in iron content within the substantia nigra.
Insights
This study introduces a new MRI method to measure brain iron concentration using T2 and T2*-weighted imaging. This technique accurately quantifies iron in the substantia nigra, differentiating Parkinson
Area of Science:
- Neuroimaging
- Biophysics
- Medical Physics
Background:
- Brain iron concentration is implicated in neurodegenerative diseases.
- Previous MRI methods have struggled to reliably correlate T2 relaxation times with brain iron.
- Quantifying T2' (the line broadening effect) and R2' (relaxation rate) may offer a more specific measure of brain iron.
Purpose of the Study:
- To present a novel method for the relative assessment of brain iron concentrations using T2 and T2*-weighted MRI.
- To introduce an improved field inhomogeneity correction technique for more accurate T2* and T2' measurements.
- To investigate the utility of this method in differentiating Parkinson's disease patients from healthy controls.
Main Methods:
- Utilized a multiecho sequence for rapid measurement of T2 and T2* relaxation times.
- Calculated T2' (line broadening) and R2' (relaxation rate) from T2 and T2* data.
- Implemented a new field inhomogeneity correction method to separate global and local effects.
- Applied T2*-weighted and T2-weighted MRI to assess iron content in the substantia nigra.
Main Results:
- The developed method allows for accurate quantification of T2' and R2', potentially serving as specific relative measures of brain iron.
- The new field inhomogeneity correction enhances the accuracy of T2* and T2' measurements.
- Combined T2*-weighted and T2-weighted MRI successfully differentiated Parkinson's disease patients from age-matched controls based on substantia nigra iron levels.
Conclusions:
- Quantification of T2' and R2' using advanced MRI techniques offers a promising approach for assessing relative brain iron concentration.
- This method holds potential for studying brain diseases associated with altered iron metabolism.
- The technique demonstrates clinical relevance by enabling the differentiation of Parkinson's disease patients via substantia nigra iron quantification.